Owner Orion Corporation

Inventors Wohlfahrt, Gerd; Tormakangas, Olli; Salo, Harri; Hoglund, Lisa; Karjalainen, Arja; Knuuttila, Pia; Holm, Patrick; Rasku, Sirpa; Vesalainen, Anniina

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010311299

PCT Pub. Number WO2011/051540

Priority 61/255,159 27.10.09 US

Filing date 27 October 2010

Wipo publication date 5 May 2011

C07D 231/14 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/42 (2006.01) - Oxazoles

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4523 (2006.01) - containing further heterocyclic ring systems

A61K 31/497 (2006.01)

A61K 31/5377 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group